Title: GROUND-BREAKING PEROVSKITE TECHNOLGIES FOR ADVANCED X-RAY MEDICAL IMAGING SYSTEMS
Acronym of the project: PEROXIS
Funding entity: European Commission
Modality: H2020-ICT-2018-2020 INFORMATION AND COMMUNICATION TECHNOLOGIES
Entity code: 7836/2018
UJI accounting code: 19I598
Principal researchers:
Total amount: 376.032,00€
Involved researchers:
Acronym of the project: PEROXIS
Funding entity: European Commission
Modality: H2020-ICT-2018-2020 INFORMATION AND COMMUNICATION TECHNOLOGIES
Entity code: 7836/2018
UJI accounting code: 19I598
Principal researchers:
- Germà Garcia-Belmonte
Total amount: 376.032,00€
Involved researchers:
- Antonio Guerrero
- Juan Bisquert
Summary/Abstract:
The PEROXIS project will develop a new X-ray imaging system with higher sensitivity and spatial resolution compared to
conventional ones, which will support diagnosis during intervention and treatments of various diseases.
The emerging semiconducting perovskite materials, largely used for photovoltaic applications, are a good candidate since
they have the potential to globally address the following ambitious objectives:
-Advancing X-ray based imaging systems for advanced diagnostics and treatments of two major diseases: cardiovascular
disease (CVD) and chronic obstructive pulmonary disease (COPD)
-Improving the efficiency and spatial resolution of flat panel X-ray detectors
-Groundbreaking perovskite-based direct conversion X-ray imaging detectors for large-area compatibility
-Validating the feasibility of phase contrast imaging for earlier detection of chronic obstructive pulmonary disease
PEROXIS is a multidisciplinary project engaging 7 EU partners from 4 countries (France, Germany, Spain and the
Netherlands) covering the academic, RTO and industrial (3 major medical equipment manufacturers) worlds. An
implementation plan is presented in the form of 8 work packages, 6 of which are technical in nature. Synergy in
communication and dissemination by the several partners and stakeholders (external advisory board mainly composed of
physicians who provide letters of intent) will permit to maximize the PEROXIS project impact.
Both solutions to overcome the fundamental technological barriers as well as appropriate deliverables, tasks, milestones and
risks in order to complete the project objectives in due time are presented. The medical sector will be highly impacted by the
PEROXIS project outcome: future applications of an improved PEROXIS imaging system will not be limited to COPD and
CVD only, but may be extended to various other clinical domains in which the performance of diagnostic driven therapy
systems is limited by current flat panel X-ray detector technology. 
